Celldex Therapeutics, Inc.CLDXNASDAQ

|||

Overview Charts News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Analyst Sentiment

Analysts lean bullish — 81% recommend buying.

Consensus Rating

Buy

16 analysts·Moderate coverage

81%

Rating Distribution

Strong Buy

00%

Buy

1381%

Hold

213%

Sell

16%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Current price is 3% above analyst consensus — near fair value expected.

Bear Case

$24.00

-3%

Consensus

$24.00

-3%

Bull Case

$24.00

+-3%

Price Range16 analysts

Low

Consensus

High

$24.00

Current Target

Current Price

$24.66

Above Target

$0.66

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$-4.50(8 analysts)

Actual

Estimate

Range (Low–High)

Stock Alarm Pro

Forward Growth Estimates (YoY)

FY2027

Rev+217.61%

EPS—

FY2028

Rev+974.54%

EPS—

FY2029

Rev+343.27%

EPS—

Earnings Surprises

Beat rate:67%(8/12 quarters)

Avg surprise:+2.0%

Beat

Miss

Inline

Estimate

Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Dec 17, 2025Barclays

Celldex price target raised to $24 from $21 at Barclays

Target:$24.00

-10.0%from $26.68

Nov 11, 2025Barclays

Celldex price target lowered to $21 from $25 at Barclays

Target:$21.00

-7.4%from $22.67

Oct 13, 2025Barclays

Celldex initiated with an Underweight at Barclays

Target:$25.00

-6.6%from $26.77

Mar 20, 2025Morgan Stanley

Celldex initiated with an Overweight at Morgan Stanley

Target:$46.00

+131.4%from $19.88

Oct 29, 2024H.C. Wainwright

H.C. Wainwright Reiterates Buy Rating on Celldex Therapeutics (CLDX)

Target:$80.00

+195.0%from $27.11

Sep 25, 2024Wells Fargo

Celldex upgraded to Overweight from Equal Weight at Wells Fargo

Target:$44.00

+22.2%from $36.02

Jun 17, 2024Stifel Nicolaus

Celldex initiated with a Buy at Stifel

Target:$58.00

+66.1%from $34.91

Nov 10, 2023Wells Fargo

Wells Fargo Upgrades Celldex Therapeutics (CLDX) to Equal Weight

Target:$27.00

+4.7%from $25.78

Nov 11, 2022Guggenheim

Guggenheim Maintains Buy on Celldex Therapeutics, Lowers Price Target to $63

Target:$63.00

+57.9%from $39.89

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance